RDF/XML JSON-LD N3/Turtle RDF/JSON

Melguizo Alonso, Consolación Author

Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells

  • Marchal, JA
  • Prados, J
  • Melguizo, C
  • Fernandez, JE
  • Velez, C
  • Alvarez, L
  • Aranega, A
... View more Collapse

Journal of Laboratory and Clinical Medicine - 1/07/1997

10.1016/s0022-2143(97)90057-3

Cite count: 19 (Web of Science) 23 (Scopus)
  • JCR Quartile: Q1 (1997)
  • JCR Impact Factor: 1.808 (2022)
  • Category normalized Impact: 0.621 (1997)

ACTINOMYCIN-D CAUSES MULTIDRUG-RESISTANCE AND DIFFERENTIATION IN A HUMAN RHABDOMYOSARCOMA CELL-LINE

  • MELGUIZO, C
  • PRADOS, J
  • FERNANDEZ, JE
  • VELEZ, C
  • ALVAREZ, L
  • ARANEGA, A

CELLULAR AND MOLECULAR BIOLOGY - 1/03/1994

Cite count: 18 (Web of Science) 17 (Scopus)
  • CiteScore: 2.5 (2020)
Open Access

5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

  • Ortiz R.
  • Prados J.
  • Melguizo C.
  • Arias J.
  • Adolfina Ruiz M.
  • Álvarez P.
  • Caba O.
  • Luque R.
  • Segura A.
  • Aránega A.
... View more Collapse

International Journal of Nanomedicine - 10/2/2012

Cite count: 48 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 3.463 (2012)
  • CiteScore: 9.2 (2020)
  • SJR: 1.041 (2012
  • SNIP: 1.543 (2012
  • JCR 5-year Impact Factor: 4.027
  • JCR Categories: PHARMACOLOGY & PHARMACY
  • SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)
Open Access

5-Fluorouracil-loaded poly(epsilon-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

  • Ortiz, Raul
  • Prados, Jose
  • Melguizo, Consolacion
  • Arias, Jose L.
  • Ruiz, M. Adolfina
  • Alvarez, Pablo J.
  • Caba, Octavio
  • Luque, Raquel
  • Segura, Ana
  • Aranega, Antonia
... View more Collapse

International Journal of Nanomedicine - 10/2/2012

10.2147/ijn.s26401

Cite count: 56 (Web of Science) 38 (Scopus)
  • JCR Quartile: Q1 (2012)
  • SJR Quartile: Q1
  • JCR Impact Factor: 3.463 (2012)
  • Category normalized Impact: 1.681 (2012)
  • CiteScore: 7.1 (2019)
  • SJR: 1.041 (2012
  • SNIP: 1.544 (2012
  • JCR 5-year Impact Factor: 4.027
  • JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
  • SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)

5-Fluorouracil derivatives: a patent review

  • Alvarez, Pablo
  • Antonio Marchal, Juan
  • Boulaiz, Houria
  • Carrillo, Esmeralda
  • Velez, Celia
  • Rodriguez-Serrano, Fernando
  • Melguizo, Consolacion
  • Prados, Jose
  • Madeddu, Roberto
  • Aranega, Antonia
... View more Collapse

EXPERT OPINION ON THERAPEUTIC PATENTS - 1/02/2012

10.1517/13543776.2012.661413

Cite count: 81 (Web of Science) 63 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 3.525 (2012)
  • Category normalized Impact: 1.318 (2012)
  • CiteScore: 9.8 (2020)
  • SJR: 1.33 (2012
  • SNIP: 1.119 (2012
  • JCR 5-year Impact Factor: 2.523
  • JCR Categories: MEDICINE, LEGAL
  • SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)

The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy

  • Boulaiz, H
  • Prados, J
  • Melguizo, C
  • Marchal, JA
  • Carrillo, E
  • Velez, C
  • Fernandez, JE
  • Alvarez, L
  • Caba, O
  • Aranega, A
... View more Collapse

CELLULAR AND MOLECULAR BIOLOGY - 06/2003

  • JCR Quartile: Q4 (2003)
  • SJR Quartile: Q1
  • JCR Impact Factor: 1.153 (2022)
  • SJR Categories: Medicine (miscellaneous) (Q1)

Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy

  • Marchal J.
  • García M.
  • Boulaiz H.
  • Perán M.
  • Álvarez P.
  • Prados J.
  • Melguizo C.
  • Aránega A.
... View more Collapse

Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012

10.1007/978-94-007-2415-0_15

Cite count:

This author has no conferences.

This author has no patents.

Open Access

Synthesis, solubility and antitumor activity of maslinic acid derivatives

  • Fuentes-Rios, D.
  • Cepero, A.
  • Garcia-Castro, M.
  • Contreras-Caceres, R.
  • Lopez-Romero, J. M.
  • Luque, C.
  • Cabeza, L.
  • Melguizo, C.
  • Prados, J.
... View more Collapse

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022

10.1016/j.ejmcr.2022.100032

Cite count: 4 (Web of Science)

Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review

  • Lidia Gago
  • Francisco Quiñonero
  • Gloria Perazzoli
  • Consolacion Melguizo
  • Jose Prados
  • Raul Ortiz
  • Laura Cabeza
... View more Collapse

Pharmaceutics - 13/06/2023

10.3390/pharmaceutics15071958

Cite count: 2 (Web of Science) 1 (Scopus)
Open Access

Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives

  • Hernández R.
  • Sánchez-Jiménez E.
  • Melguizo C.
  • Prados J.
  • Rama A.R.

BMB Reports - 1/1/2018

10.5483/bmbrep.2018.51.11.116

Cite count: 19 (Web of Science) 12 (Scopus)
  • SJR Quartile: Q1
  • JCR Impact Factor: 2.966 (2018)
  • CiteScore: 6 (2020)
  • SJR: 1.082 (2018
  • SNIP: 0.952 (2018
  • JCR 5-year Impact Factor: 2.838
  • JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
  • SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)

Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)

  • Ballesteros A.
  • Hernández R.
  • Perazzoli G.
  • Cabeza L.
  • Melguizo C.
  • Vélez C.
  • Prados J.
... View more Collapse

CANCER GENE THERAPY - 1/1/2020

10.1038/s41417-020-0166-y

Cite count:
  • JCR Impact Factor: 5.987 (2020)
  • CiteScore: 8.1 (2020)
  • SJR: 1.535 (2020
  • SNIP: 1.113 (2020
  • JCR 5-year Impact Factor: 5.358
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL

Scopus: 27

Web of Science: 30

Scopus: 78

Web of Science: 90

Last data update: 5/18/24 7:53 AM
Next scheduled update: 5/25/24 3:00 AM